CWGCX
Price
$67.22
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
MWECX
Price
$42.33
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

CWGCX vs MWECX

Header iconCWGCX vs MWECX Comparison
Open Charts CWGCX vs MWECXBanner chart's image
American Funds Capital World Gr&Inc C
Price$67.22
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
MFS Global Equity C
Price$42.33
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CWGCX vs MWECX Comparison Chart
Loading...
VS
CWGCX vs. MWECX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a StrongBuy and MWECX is a StrongBuy.

FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 125B vs. MWECX (2.49B). CWGCX pays higher dividends than MWECX: CWGCX (1.04) vs MWECX (0.05). CWGCX was incepted earlier than MWECX: CWGCX (24 years) vs MWECX (31 years). CWGCX is a more actively managed with annual turnover of: 27.00 vs. MWECX (8.00). CWGCX has a lower initial minimum investment than MWECX: CWGCX (250) vs MWECX (1000). CWGCX annual gain was more profitable for investors over the last year : 19.12 vs. MWECX (4.93). CWGCX return over 5 years is better than : 40.68 vs. MWECX (5.35).
CWGCXMWECXCWGCX / MWECX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years31 years-
Gain YTD11.8567.967149%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets125B2.49B5,024%
Annual Yield % from dividends1.040.052,227%
Returns for 1 year19.124.93388%
Returns for 3 years4.41-19.35-23%
Returns for 5 years40.685.35761%
Returns for 10 years45.0131.50143%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNFT4.340.11
+2.60%
Genfit SA
CCL18.360.33
+1.83%
Carnival Corp
IMNM15.500.10
+0.65%
Immunome
PGNY24.44-0.38
-1.53%
Progyny
MTNB3.52-0.07
-2.00%
Matinas Biopharma Holdings Inc